Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-22 Behar Gregory Director Grant or award · Stock Option (right to buy) +35,000 35,000
2022-06-22 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2022-06-22 Berenson Stephen Director Grant or award · Stock Option (right to buy) +35,000 35,000
2022-06-22 Dere Willard H Director Grant or award · Stock Option (right to buy) +35,000 35,000
2022-06-15 Arkowitz David Chief Financial Officer Exercise or conversion +5,000 70,492
2022-06-15 Arkowitz David Chief Financial Officer Exercise or conversion · Restricted Stock Units −5,000 0
2022-02-07 Cloghessy Paula Grant or award · Stock Options (right to buy) +190,000 190,000
2022-02-04 Ege David S. Grant or award · Stock Option (Right to Buy) +175,000 175,000
2022-02-04 Young Teresa L. Grant or award · Stock Option (Right to Buy) +120,000 120,000
2022-02-04 von Moltke Lisa Grant or award · Stock Option (Right to Buy) +175,000 175,000
2022-02-04 Arkowitz David Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-02-04 Shaff Eric D. President, CEO Grant or award · Stock Option (Right to Buy) +500,000 500,000
2022-02-04 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Stock Option (Right to Buy) +130,000 130,000
2022-02-04 Henn Matthew R. Grant or award · Stock Option (Right to Buy) +175,000 175,000
2021-06-16 Biondi Paul Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-16 Berenson Stephen Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-16 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-16 Graves Kurt Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-16 Behar Gregory Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-16 Dere Willard H Director Grant or award · Stock Option (right to buy) +23,000 23,000

Page 21 of 23 · 458 trades